Boston University Medical Center
 
Tutorial Home
Library Home Questions/Comments Medline Login
Other Resources
 

Tutorial Instructions

Searchable Questions

About MEDLINE

Keyword/Textword

Searching


Medical Subject Headings

Overview 1

Mapping

Subheadings

MeSH Tree

Explode

Focus

Combining (AND, OR)

Combining Overview

Limiting

Displaying Results

Full Text Articles

Printing/E-Mailing/Saving

Ordering Articles



DISPLAYING RESULTS
Screen 3 of 3


This is the COMPLETE REFERENCE.

Search Results
Ask a LibrarianHelpLogoff
 
Results Manager
Results of your search: *Estrogen Replacement Therapy/
Viewing 2 of 5252 Results
Go to #:

If you want to select this article for printing or saving, you could click in the checkbox (beside Result 2.) before going on to the next result or returning to the main search page.

Scroll down the screen to review the various citation fields and options that are available in a complete reference.


Result 2.
|
Link to...
Unique Identifier16193292
Record OwnerNLM
AuthorsGodsland IF.
Authors Full NameGodsland, I F.
InstitutionDepartment of Endocrinology and Metabolic Medicine, Imperial College London, St Mary's Hospital, UK. i.godsland@imperial.ac.uk
TitleOestrogens and insulin secretion. [Review] [50 refs]
SourceDiabetologia. 48(11):2213-20, 2005 Nov.
Abbreviated SourceDiabetologia. 48(11):2213-20, 2005 Nov.
NLM Journal NameDiabetologia.
Publishing ModelJournal available in: Print-Electronic
Citation processed from: Print
NLM Journal Codee93, 0006777
Journal SubsetIM
Local MessagesAlumni Medical Library owns some volumes. Check "Library Holdings" for details.
Country of PublicationGermany
MeSH Subject Headings Animals
Carbohydrate Metabolism
*Diabetes Mellitus / ep [Epidemiology]
Diabetes Mellitus / me [Metabolism]
Diabetes Mellitus, Experimental / dt [Drug Therapy]
*Estrogen Replacement Therapy
*Estrogens / me [Metabolism]
Estrogens / pd [Pharmacology]
*Estrogens / tu [Therapeutic Use]
Female
Humans
Incidence
*Insulin / se [Secretion]
Insulin Resistance
Insulin-Secreting Cells / se [Secretion]
Postmenopause
Prevalence
Research Support, Non-U.S. Gov't
During a live OVID session, you can click on any of the MeSH above to find articles on the same topic(s).

Examining the MeSH is a good way to find clues to improve your search results. Often, you'll discover useful MeSH headings that can be incorporated into your search.

AbstractThere is a persistent perception that oestrogens have an adverse effect on carbohydrate metabolism. It might therefore be expected that their use would result in a corresponding increase in the incidence of diabetes. Recent evidence from clinical trials suggesting that women on postmenopausal oestrogen hormone replacement therapy (HRT) have a reduced incidence of type 2 diabetes therefore appears paradoxical. Short-term supraphysiological oestrogen administration has an adverse effect on glucose tolerance, resulting from suppression of first-phase insulin secretion and increased insulin resistance. Oestrogen-induced increases in glucocorticoid activity could account for these effects. Oestrogen-induced deterioration in glucose tolerance is, however, accompanied by a reduction in fasting glucose, an effect that could be accounted for by glucagon antagonism. These short-term effects contrast with long-term preservation of insulin secretion and glucose homeostasis by oestrogens. In animal studies, ovariectomy is associated with decreased insulin secretion and increased risk of diabetes, whereas oestrogen administration protects against diabetes and increases the insulin response to glucose. The mechanism is uncertain, but direct effects on the pancreas via steroid receptors or indirect effects via oestrogen-induced glucagon antagonism and subclinical increases in glucocorticoids and growth hormone could all contribute. Recent evidence that HRT increases the risk of cardiovascular disease suggests that it should not be used for the prevention of diabetes, but the mechanism responsible for this benefit merits further investigation and might lead to new therapies. [References: 50]
CAS Registry/EC Number/Name of Substance0 (Estrogens). 11061-68-0 (Insulin).
ISSN Print0012-186X
Publication TypeJournal Article. Review.
LanguageEnglish
Electronic Date of Publication20050929
Date of Publication2005 Nov
Entry Date20060126
Update Date20060127

Now let's move on to the FULL TEXT DISPLAY options.